The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'.
about
Cytomegalovirus-induced immunopathology and its clinical consequencesA rare case of Cytomegalovirus, Scedosporium apiospermum and Mycobacterium tuberculosis in a renal transplant recipient.Thoracic CT findings of novel influenza A (H1N1) infection in immunocompromised patients.Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes.Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation modelPost-transplant lymphoproliferative disorder resembling Wilms tumor. Diagnostic dilemma: renal biopsy or nephrectomy?Serological markers of viral, syphilitic and toxoplasmic infection in children and teenagers with nephrotic syndrome: case series from Mato Grosso State, BrazilEffects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patientsPre-Transplant Screening for Latent Adenovirus in Donors and Recipients.Immunobiology of human cytomegalovirus: from bench to bedside.Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.Monitoring and managing viral infections in pediatric renal transplant recipients.Opportunistic viral infections in intestinal transplantation.Epigenetic regulation of human cytomegalovirus latency: an update.Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation?The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children.Hepatic decompensation in the absence of obvious precipitants: the potential role of cytomegalovirus infection/reactivation.Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction.Cytomegalovirus transmission in pediatric renal transplant recipients during the window period.Liquid chromatography tandem mass spectrometry quantitation of intracellular concentrations of ganciclovir and its phosphorylated forms.Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains.Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients.Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation.Incidence, risk factors, and outcomes associated with cytomegalovirus disease in small bowel transplant recipients.Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival.
P2860
Q21195897-BA850F1D-F734-4D94-9B06-863861BC26B4Q33654417-578CE210-3AE7-42D3-B58C-247C394789D2Q33892138-8343009F-9553-4CCA-BCBA-EDBA8D9CA70CQ34077023-9DF00D42-1C5A-43A4-ADF4-2659B74C90AAQ34251742-286F4252-45C1-4EAA-BD3E-9B94682BF535Q34622006-D69EB210-442B-44A8-8721-C3D19E5C2871Q34977267-4B63ED64-DA9E-4998-A8AF-A177E02A96B8Q36321541-5CAA2361-AE0D-4EDA-BC70-1F361F86C2C9Q36658623-BDF83BF1-29F0-4D07-A93A-8DA8FDF2318BQ37050965-34DE8252-B74D-48F9-A1FF-CED36FE2E858Q37559627-4BCD41F5-473B-4C7D-B5AD-8FEDF0270A7CQ37848137-BAD15244-15CB-44EB-B135-8F14F172AAC4Q38097119-3EEC4A0A-6D4B-4F5A-A40A-88C8A96ECA74Q38272313-D778F21E-BE76-4F3A-8045-32816EB8E162Q38475761-7C0E8E09-3EB9-49AB-B99E-CDB8C8739F71Q39321579-C898AACA-C55B-4B8F-8EEF-661ED5438B7BQ39409484-1D9B9E1C-8263-4181-A4AC-5F1BECB1E93DQ40278985-1AE23981-8B32-4067-9B51-60830711DEC3Q40862316-3977F254-9222-498F-91E2-961FEA00723FQ41471865-C055C6E3-794E-4ADB-9F31-F90F6E7A0130Q42208366-A223BC40-6D59-4424-9929-D2869950F6DCQ42267746-57DE8B31-D2DD-497C-B1B9-E67CC1D7B7CBQ47142154-3F35C65F-F6E0-4100-A5B4-81241D29311EQ51370683-8076FE52-13F2-4AEF-9A4F-27E91185850EQ54345873-18F41771-67D2-4A02-8B41-5DEA48F6AAE4
P2860
The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The pathogenesis and clinical ...... end of the 'silo hypothesis'.
@en
type
label
The pathogenesis and clinical ...... end of the 'silo hypothesis'.
@en
prefLabel
The pathogenesis and clinical ...... end of the 'silo hypothesis'.
@en
P1476
The pathogenesis and clinical ...... end of the 'silo hypothesis'.
@en
P2093
Robert H Rubin
P304
P356
10.1097/QCO.0B013E328285A358
P577
2007-08-01T00:00:00Z